Evidence map›Paper›PMID 25845879›Full record

ArticleAntimicrobial agents and chemotherapy2015

Ibuprofen potentiates the in vivo antifungal activity of fluconazole against Candida albicans murine infection.

Sofia Costa-de-Oliveira, Isabel M Miranda, Ana Silva-Dias, Ana P Silva, Acácio G Rodrigues, Cidália Pina-Vaz

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Article
  3. Antifungal activities and toxicity studies of water-soluble non-steroidal analgesic salts.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Drug resistance and tolerance in fungi.Nature reviews. Microbiology · 2020
    Review
  12. Microorganisms · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sofia Costa-de-OliveiraDepartment of Microbiology, Faculty of Medicine, University of Porto, Porto, Portugal CINTESIS-Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal sqco@med.up.pt.ORCID http://orcid.org/0000-0003-2899-6615
Isabel M MirandaDepartment of Microbiology, Faculty of Medicine, University of Porto, Porto, Portugal CINTESIS-Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal.
Ana Silva-DiasDepartment of Microbiology, Faculty of Medicine, University of Porto, Porto, Portugal CINTESIS-Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal.
Ana P SilvaDepartment of Microbiology, Faculty of Medicine, University of Porto, Porto, Portugal CINTESIS-Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal.
Acácio G RodriguesDepartment of Microbiology, Faculty of Medicine, University of Porto, Porto, Portugal CINTESIS-Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal Burn Unit, Department of Plastic and Reconstructive Surgery, Hospital São João, Porto, Portugal.
Cidália Pina-VazDepartment of Microbiology, Faculty of Medicine, University of Porto, Porto, Portugal CINTESIS-Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal Burn Unit, Department of Plastic and Reconstructive Surgery, Hospital São João, Porto, Portugal Department of Microbiology, Hospital São João, Porto, Portugal.
Universidade do Porto · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candida albicans is the most prevalent cause of fungemia worldwide. Its ability to develop resistance in patients receiving azole antifungal therapy is well documented. In a murine model of systemic infection, we show that ibuprofen potentiates fluconazole antifungal activity against a fluconazole-resistant strain, drastically reducing the fungal burden and morbidity. The therapeutic combination of fluconazole with ibuprofen may constitute a new approach for the management of antifungal therapeutics to reverse the resistance conferred by efflux pump overexpression.

Indexed as

AnimalsAntifungal AgentsAnti-Inflammatory Agents, Non-SteroidalCandida albicansCandidiasisDrug Resistance, FungalDrug SynergismFemaleFluconazoleFungal ProteinsIbuprofenMembrane Transport ProteinsMiceMice, Inbred BALB CMicrobial Sensitivity TestsAntifungal AgentsAnti-Inflammatory Agents, Non-SteroidalCDR1 protein, Candida albicansFluconazoleFungal ProteinsIbuprofenMembrane Transport Proteins

Identifiers

PMID25845879
PMCPMC4468673
OpenAlexW2014081530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.